Japan MHLW Establishes New Flu Policy Guidance
This article was originally published in PharmAsia News
The Minister of Health, Labor and Welfare Yoichi Masuzoe June 19 announced a new policy to prepare for the second wave of flu infection, estimated to arrive during the fall to winter session. The new policy calls for patients with light flu symptoms to rest at home, and all medical facilities should treat new flu cases. MHLW also announced a halt in seasonal flu vaccine manufacturing and a start of new flu vaccine production from mid-July. The Minister estimates that within the year, four Japanese vaccine makers will produce vaccines for 2.5 million people, and new flu vaccinations will be available in October. Japan has yet to decide who will be among the first to be vaccinated. (Click here for more - Japanese language
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.